Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 3, 2010, Pages 464-470

  Kitanaka, Junichi ^a   Kitanaka, Nobue ^a   Tatsuta, Tomohiro ^a   Miyoshi, Akio ^a   Koumoto, Atena ^a   Tanaka, Koh ichi ^b   Nishiyama, Nobuyoshi ^b   Morita, Yoshio ^a   Takemura, Motohiko ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Division of Pharmacology   (Japan)

Author keywords

Histaminergic neurotransmission; Hypothalamus; l Histidine; Methamphetamine; Stereotypy

Indexed keywords

CLOBENPROPIT; FEXOFENADINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTIDINE; KETOTIFEN FUMARATE; MEPYRAMINE; METHAMPHETAMINE; THIOPERAMIDE; ZOLANTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BITE; BLOOD BRAIN BARRIER; CIRCLING BEHAVIOR; CONTROLLED STUDY; HYPOTHALAMUS; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SNIFFING; STEREOTYPY;

ANIMALS; BITES AND STINGS; HISTAMINE; HISTIDINE; HYPOTHALAMUS; LOCOMOTION; MALE; METHAMPHETAMINE; METHYLHISTAMINES; MICE; MICE, INBRED ICR; STEREOTYPED BEHAVIOR;

MUS;

EID: 71849099884     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.10.009     Document Type: Article

References (30)

1. Aman M.G. Stimulant drug effects in developmental disorders and hyperactivity - toward a resolution of disparate findings. J Autism Dev Disord 12 (1982) 385-398
2. 3-receptors control histamine release in human brain. J Neurochem 51 (1988) 105-108
3. Beaven M.A., and Shaff R.E. Inhibition of histamine methylation in vivo by the dimaprit analog, SKF compound 91488. Agents Actions 9 (1979) 455-460
4. Borison R.L., Havdala H.S., and Diamond B.I. Chronic phenylethylamine stereotypy in rats: a new animal model of schizophrenia?. Life Sci 21 (1977) 117-122
5. 3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology (Berl) 202 (2009) 673-687
6. 3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol 259 (1994) 107-114
7. Costall B., and Naylor R.J. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei. Eur J Pharmacol 29 (1974) 206-222
8. Creese I., and Iversen S.D. Blockade of amphetamine induced motor stimulation and stereotype in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 55 (1973) 369-382
9. Duch D.S., Bowers S.W., and Nichol C.A. Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase. Biochem Pharmacol 27 (1978) 1507-1509
10. 3 receptor antagonist. J Pharmacol Exp Ther 313 (2005) 176-190
11. Ito C., Onodera K., Watanabe T., and Sato M. Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats. Psychopharmacology (Berl) 130 (1997) 362-367
12. Itoh Y., Nishibori M., Oishi R., and Saeki K. Neuronal histamine inhibits methamphetamine-induced locomotor activity in mice. Neurosci Lett 48 (1984) 305-309
13. Iversen S.D. Neural substrates mediating amphetamine responses. In: Ellinwood Jr. E.H., and Kilbey M.M. (Eds). Advances in behavioral biology. Cocaine and other stimulants vol. 21 (1977), Plenum Press, New York 31-45
14. Joshi V.V., Balsara J.J., Jadhav J.H., and Chandorkar A.G. Effect of l-histidine and chlorcyclizine on apomorphine-induced climbing behavior and methamphetamine stereotypy in mice. Eur J Pharmacol 69 (1981) 499-502
15. Kalivas P.W. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J Pharmacol Exp Ther 222 (1982) 37-42
16. Kitanaka N., Kitanaka J., and Takemura M. Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur J Pharmacol 474 (2003) 63-70
17. Kitanaka J., Kitanaka N., Tatsuta T., and Takemura M. 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice. Pharmacol Biochem Behav 82 (2005) 488-494
18. 1 receptors. Neuroscience 147 (2007) 765-777
19. 3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice. Life Sci 61 (1997) 355-361
20. Mori T., Ito S., Kita T., and Sawaguchi T. Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. J Pharmacol Sci 96 (2004) 459-464
21. Moy S.S., Nadler J.J., Poe M.D., Nonneman R.J., Young N.B., Koller B.H., et al. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 188 (2008) 178-194
22. Prell G.D., and Green J.P. Histamine as a neuroregulator. Annu Rev Neurosci 9 (1986) 209-254
23. Rebec G.V., and Bashore T.R. Critical issues in assessing the behavioral effects of amphetamine. Neurosci Biobehav Rev 8 (1984) 153-159
24. Sakai N., Onodera K., Maeyama K., Yanai K., and Watanabe T. Effects of (S)-α-fluoromethylhistidine and metoprine on locomotor activity and brain histamine content in mice. Life Sci 51 (1992) 397-405
25. Segal D.S., and Kuczenski R. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 17 (1997) 2551-2566
26. Takemura M., Kitanaka N., and Kitanaka J. Signal transduction by histamine in the cerebellum and its modulation by N-methyltransferase. Cerebellum 2 (2003) 39-43
27. Tatsuta T., Kitanaka N., Kitanaka J., Morita Y., and Takemura M. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats. Neurochem Res 30 (2005) 1377-1385
28. Taylor K.M., and Snyder S.H. Dynamics of the regulation of histamine levels in mouse brain. J Neurochem 19 (1972) 341-354
29. Winchel R.M., and Stanley M. Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am J Psychiatry 148 (1991) 306-317
30. Woods-Kettelberger A., Kongsamut S., Smith C.P., Winslow J.T., and Corbett R. Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder. Expert Opin Invest Drugs 6 (1997) 1369-1381